RICHARD NEWPORT: Open Payments
NPI 1770633513 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,442 in 31 payments from 11 companies in 2025. Trend: 2023 $748 · 2024 $580 · 2025 $1,442
Speaker / faculty: $975Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 1 | $975 |
| Axsome Therapeutics, Inc. | 14 | $138 |
| Lilly USA, LLC | 3 | $63 |
| ABBVIE INC. | 3 | $57 |
| Novo Nordisk Inc | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Eisai Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $28 |
| Amgen Inc. | 1 | $26 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $22 |
Products named: Sohonos, Auvelity, JARDIANCE, VRAYLAR, Ozempic, REXULTI, Leqembi, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
